MINNEAPOLIS, Oct. 18 /PRNewswire/ -- CoreSpine Technologies LLC, an emerging spinal device company located in Minneapolis, Minnesota announced today the completion of the company's initial cadaver evaluations.
CoreSpine's first product in development is a complete nucleus removal device that seeks to remove the nucleus pulposus from the lumbar disc space, while not damaging the annulus or endplates. In addition, its design characteristics allow the device to be used in multiple surgical approaches, including the preferred posterior approach.
"This set of successful evaluations illustrates that the prototype has made progress towards a device that addresses the clinical needs for safe and complete nucleus resection," said John Sherman, M.D., Medical Director for CoreSpine. Dr. Sherman continued, "The device created a larger nucleus cavity than the rongeur and damage to the annulus and endplates was minimized."
"We're pleased with the data that was generated from the labs. As Dr. Sherman stated, the results of the initial work are promising and will be used to guide the near-term engineering refinements, "said Britt Norton, Co-Founder of CoreSpine Technologies. Mr. Norton continued, "CoreSpine has submitted data and information for presentation at international spine meetings in 2008."
About CoreSpine Technologies, LLC
CoreSpine Technologies is a privately held medical device company. It is focused solely on the design and development of improved nucleus removal devices, which will be a crucial step in the optimum placement of nucleus replacement and minimally invasive fusion implants. CoreSpine's first products will mechanically remove the nucleus from the lumbar disc space, while sparing annulus and endplate tissues. For additional information, please contact Christine Horton at firstname.lastname@example.org or Britt Norton at email@example.com, or visit the company's website at http://www.corespinetech.com.
CONTACT: Christine M. Horton, Founder, CoreSpine Technologies,
Web site: http://www.corespinetech.com/